Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Purple Biotech Ltd. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −1 vs. Q2 2021
- Shares held
- 1.15M
- +388.0K (+50.9%) vs. Q2 2021
- Total value
- $5.27M
- +$1.55M (+41.6%) vs. Q2 2021
- New holders
- 4
- 1 more added
- Sold out
- 5
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $141.0K |
| Q1 2026 | 15 | $305.6K |
| Q4 2025 | 19 | $513.2K |
| Q3 2025 | 16 | $75.9K |
| Q2 2025 | 14 | $133.7K |
| Q1 2025 | 9 | $134.3K |
| Q4 2024 | 14 | $377.9K |
| Q3 2024 | 11 | $946.1K |
| Q2 2024 | 21 | $775.9K |
| Q1 2024 | 21 | $1.77M |
| Q4 2023 | 20 | $1.90M |
| Q3 2023 | 18 | $275.9K |
| Q2 2023 | 17 | $388.3K |
| Q1 2023 | 16 | $224.2K |
| Q4 2022 | 15 | $238.6K |
| Q3 2022 | 11 | $224.0K |
| Q2 2022 | 14 | $310.2K |
| Q1 2022 | 14 | $1.77M |
| Q4 2021 | 13 | $4.09M |
| Q3 2021 | 12 | $5.27M |
| Q2 2021 | 13 | $3.72M |
| Q1 2021 | 15 | $2.40M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 736,019 | $3.37M | 0.01% | +736,019 | New |
| Point72 Asset Management, L.P. | 279,294 | $1.28M | 0.01% | −245,706−46.8% | Reduced |
| Group One Trading, L.P. | 46,879 | $214.0K | 0.00% | +4,598+10.9% | Added |
| Morgan Stanley | 23,560 | $108.0K | 0.00% | −14,428−38.0% | Reduced |
| Condor Capital Management | 21,000 | $96.0K | 0.01% | 00.0% | Unchanged |
| Washington Trust Bank | 16,454 | $75.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 12,666 | $57.0K | 0.00% | +12,666 | New |
| Venture Visionary Partners LLC | 10,068 | $46.0K | 0.00% | +10,068 | New |
| UBS Group AG | 4,079 | $19.0K | 0.00% | −17,090−80.7% | Reduced |
| North Star Investment Management Corp. | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Meridian Wealth Partners, LLC | 295 | $1.00K | 0.00% | +295 | New |
| Walled Lake Planning & Wealth Management, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 0 | $0 | 0.00% | −50,590−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −28,177−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −17,712−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,945−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |